Related Experiment Video

Updated: Sep 27, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

[Genotypic analysis of hepatitis C viruses and its significance in interferon treatment]

H Zhao1, B Cheng, H Guo

  • 1First Affilicated Hospital of Shanxi University of Medical Sciences, Taiyuan 030001.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology
|January 8, 2003
PubMed

Insights

Hepatitis C virus (HCV) genotype II infection in Shanxi Province responds better to interferon therapy than genotype I. Genotype appears crucial for predicting treatment outcomes in chronic hepatitis C patients.

Area of Science:

  • Hepatology
  • Virology
  • Genetics

Context:

  • Hepatitis C virus (HCV) infection remains a significant global health concern.
  • Understanding HCV genotype distribution is crucial for effective treatment strategies.
  • Interferon-based therapies have been a cornerstone in managing chronic hepatitis C.

Purpose:

  • To determine the predominant HCV genotypes in Shanxi Province.
  • To evaluate the efficacy of interferon therapy across different HCV genotypes.
  • To identify factors influencing treatment response in chronic hepatitis C patients.

Summary:

  • Restriction fragment length polymorphism analysis identified HCV genotype I as the most prevalent (85.1%) in Shanxi Province, followed by genotype II (12.8%).
  • A cohort of 45 patients received recombinant interferon alpha-1b (rIFN alpha-1b) treatment.
  • Patients with HCV genotype II exhibited significantly higher response rates (80%) and sustained response rates (60%) compared to those with genotype I (37.1% and 17.1%, respectively).

Impact:

  • This study highlights HCV genotype as a critical predictor of interferon treatment response in chronic hepatitis C.
  • Findings suggest tailored therapeutic approaches based on genotype may improve patient outcomes.
  • The data underscores the importance of regional genotype surveillance for optimizing hepatitis C management strategies.

More Related Videos

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...